Latest Management of cancer Stories
MONMOUTH JUNCTION, N.J., April 24, 2015 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb®
PINEHURST, N.C., April 24, 2015 /PRNewswire-iReach/ -- Assisi Animal Health is the developer of the Assisi Loop(TM), an effective non-pharmaceutical and anti-inflammatory device (NPAID).
New Coverage Guidelines Put Children & Adults Diagnosed with Cancer at Risk WASHINGTON, April 23, 2015 /PRNewswire-USNewswire/ -- The Oregon HERC coverage guidance on
The adoption of Syapse Precision Medicine Platform will help deliver large-scale genomic and clinical data to enhance patient care SEATTLE, April 23, 2015 /PRNewswire-USNewswire/ --
MAINZ, Germany, April 22, 2015 /PRNewswire/ -- Potential for truly personalized treatment of any cancer BioNTech AG [http://www.biontech.de
Results presented at American Association of Cancer Research Annual Meeting 2015, Philadelphia, April 18-22 PHILADELPHIA, April 22, 2015 /PRNewswire/ -- Researchers at the Cancer Research
Modified Citrus Pectin could help overcome prostate cancer radio-resistance PHILADELPHIA, April 22, 2015 /PRNewswire/ -- Scientists at Tel Aviv Medical Center, Israel, have
National cancer research nonproft raises money to fund cell and gene therapy research Stamford, CT (PRWEB) April 21, 2015 Alliance for Cancer Gene Therapy
GUILDFORD, England, April 20, 2015 /PRNewswire/ -- ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is pleased to announce that the Sidney Kimmel Cancer Center at Thomas Jefferson
Collaboration to provide expanded use of Paradigm Cancer Diagnostic (PCDx(TM)) service by oncologists across large oncology network SCOTTSDALE, Ariz.
- An armed gangster.